• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清尿酸变化轨迹与非酒精性脂肪性肝病风险:一项前瞻性队列研究

Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study.

作者信息

Ma Zhimin, Xu Chaonan, Kang Xiaoping, Zhang Shan, Li Haibin, Tao Lixin, Zheng Deqiang, Guo Xiuhua, Yang Xinghua

机构信息

School of Public Health, Capital Medical University, NO. 10 Xitoutiao, Youanmen, Fengtai District, Beijing, 100069, China.

Beijing Municipal Key Laboratory of Clinical Epidemiology, NO. 10 Xitoutiao, Youanmen, Fengtai District, Beijing, 100069, China.

出版信息

J Transl Med. 2020 Mar 19;18(1):133. doi: 10.1186/s12967-020-02296-x.

DOI:10.1186/s12967-020-02296-x
PMID:32192511
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7081554/
Abstract

BACKGROUND

It is unclear the role of longitudinal trajectory of serum uric acid (SUA) on the development of non-alcoholic fatty liver disease (NAFLD). We aimed to determine whether longitudinal SUA trajectories are associated with the risk of new-onset NAFLD.

METHODS

We explored the relationship between SUA trajectories and NAFLD in a cohort including 3822 participants. Individual's SUA trajectories from 2012 to 2014 were defined using group-based trajectory modeling analysis in four distinct patterns: trajectory 1 (n = 991, 25.93%), trajectory 2 (n = 1421, 37.18%), trajectory 3 (n = 1156, 30.22%), and trajectory 4 (n = 254, 6.67%). The logistic regression model was used to evaluate the association between SUA changing trajectories and subsequent NAFLD until 2016. Dose-response relationship between SUA changing trajectories and NAFLD risk was evaluated through the testing of trajectory groups as a continuous variable.

RESULTS

The 2-year incidence of NAFLD was 13.27%. Compared with trajectory 1, the adjusted odds risk for NAFLD development was in a dose-response relationship as follows: 1.27 (95% CI 0.91-1.78) for trajectory 2, 1.89 (95% CI 1.29-2.75) for trajectory 3, and 2.34 (95% CI 1.43-3.83) for trajectory 4. And this dose-response relationship was not affected by age, sex, and abdominal obesity.

CONCLUSIONS

Higher SUA changing trajectory is a risk factor for NAFLD. This finding highlights the importance of paying attention to SUA changing trajectory on the detection and prevention of NAFLD.

摘要

背景

血清尿酸(SUA)的纵向轨迹在非酒精性脂肪性肝病(NAFLD)发展中的作用尚不清楚。我们旨在确定SUA的纵向轨迹是否与新发NAFLD的风险相关。

方法

我们在一个包含3822名参与者的队列中探讨了SUA轨迹与NAFLD之间的关系。使用基于组的轨迹建模分析将个体在2012年至2014年的SUA轨迹定义为四种不同模式:轨迹1(n = 991,25.93%)、轨迹2(n = 1421,37.18%)、轨迹3(n = 1156,30.22%)和轨迹4(n = 254,6.67%)。使用逻辑回归模型评估SUA变化轨迹与至2016年后续NAFLD之间的关联。通过将轨迹组作为连续变量进行检验来评估SUA变化轨迹与NAFLD风险之间的剂量反应关系。

结果

NAFLD的2年发病率为13.27%。与轨迹1相比,NAFLD发生的调整后比值风险呈剂量反应关系如下:轨迹2为1.27(95%CI 0.91 - 1.78),轨迹3为1.89(95%CI 1.29 - 2.75),轨迹4为2.34(95%CI 1.43 - 3.83)。并且这种剂量反应关系不受年龄、性别和腹型肥胖的影响。

结论

较高的SUA变化轨迹是NAFLD的一个危险因素。这一发现凸显了关注SUA变化轨迹对NAFLD检测和预防的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dec/7081554/33821e473c81/12967_2020_2296_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dec/7081554/de1696b080e2/12967_2020_2296_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dec/7081554/33821e473c81/12967_2020_2296_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dec/7081554/de1696b080e2/12967_2020_2296_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2dec/7081554/33821e473c81/12967_2020_2296_Fig2_HTML.jpg

相似文献

1
Changing trajectories of serum uric acid and risk of non-alcoholic fatty liver disease: a prospective cohort study.血清尿酸变化轨迹与非酒精性脂肪性肝病风险:一项前瞻性队列研究
J Transl Med. 2020 Mar 19;18(1):133. doi: 10.1186/s12967-020-02296-x.
2
C-Peptide: A Mediator of the Association Between Serum Uric Acid to Creatinine Ratio and Non-Alcoholic Fatty Liver Disease in a Chinese Population With Normal Serum Uric Acid Levels.C肽:正常血尿酸水平中国人群中血清尿酸与肌酐比值和非酒精性脂肪性肝病关联的介导因子
Front Endocrinol (Lausanne). 2020 Nov 19;11:600472. doi: 10.3389/fendo.2020.600472. eCollection 2020.
3
Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.血清尿酸水平升高预示非酒精性脂肪性肝病:一项为期 4 年的前瞻性队列研究。
Front Endocrinol (Lausanne). 2020 Apr 9;11:179. doi: 10.3389/fendo.2020.00179. eCollection 2020.
4
Conjunctional Relationship between Serum Uric Acid and Serum Nickel with Non-Alcoholic Fatty Liver Disease in Men: A Cross-Sectional Study.血清尿酸与血清镍在男性非酒精性脂肪肝病中的联合关系:一项横断面研究。
Int J Environ Res Public Health. 2022 May 25;19(11):6424. doi: 10.3390/ijerph19116424.
5
Dose-response relationship between distinct serum uric acid trajectories and metabolic syndrome risk: A 5-year prospective cohort study.不同血清尿酸轨迹与代谢综合征风险之间的剂量反应关系:一项5年的前瞻性队列研究。
Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):1189-1199. doi: 10.1016/j.numecd.2020.12.007. Epub 2020 Dec 11.
6
Sex-specific metabolic risk factors and their trajectories towards the non-alcoholic fatty liver disease incidence.性别特异性代谢风险因素及其与非酒精性脂肪性肝病发病率的关系轨迹。
J Endocrinol Invest. 2022 Dec;45(12):2233-2245. doi: 10.1007/s40618-022-01848-w. Epub 2022 Jul 27.
7
Serum Uric Acid Is a Mediator of the Association Between Obesity and Incident Nonalcoholic Fatty Liver Disease: A Prospective Cohort Study.血清尿酸是肥胖与非酒精性脂肪性肝病发病风险关联的中介物:一项前瞻性队列研究。
Front Endocrinol (Lausanne). 2021 May 13;12:657856. doi: 10.3389/fendo.2021.657856. eCollection 2021.
8
The Association between Serum Uric Acid Levels and 10-Year Cardiovascular Disease Risk in Non-Alcoholic Fatty Liver Disease Patients.血清尿酸水平与非酒精性脂肪性肝病患者 10 年心血管疾病风险的关系。
Int J Environ Res Public Health. 2022 Jan 18;19(3):1042. doi: 10.3390/ijerph19031042.
9
Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.非肥胖绝经后女性血清尿酸水平与肝脂肪变性的关系。
Climacteric. 2014 Dec;17(6):692-9. doi: 10.3109/13697137.2014.926323. Epub 2014 Aug 7.
10
The correlation between NAFLD and serum uric acid to serum creatinine ratio.非酒精性脂肪性肝病与血清尿酸与血清肌酐比值的相关性。
PLoS One. 2023 Jul 18;18(7):e0288666. doi: 10.1371/journal.pone.0288666. eCollection 2023.

引用本文的文献

1
Associations of serum uric acid trajectories with hypertension risk: exploring differences between age groups.血清尿酸轨迹与高血压风险的关联:探索年龄组间差异
Front Cardiovasc Med. 2025 Jul 4;12:1594142. doi: 10.3389/fcvm.2025.1594142. eCollection 2025.
2
Combined effect of fasting blood glucose and serum uric acid on nonalcoholic fatty liver disease.空腹血糖与血清尿酸对非酒精性脂肪性肝病的联合作用
Lipids Health Dis. 2025 May 8;24(1):168. doi: 10.1186/s12944-025-02538-1.
3
Serum uric acid trajectories and risk of metabolic dysfunction-associated steatotic liver disease in China: a 2019-2021 cohort health survey.

本文引用的文献

1
Nonalcoholic Fatty Liver Disease: What Does the Primary Care Physician Need to Know?非酒精性脂肪性肝病:基层医生需要了解什么?
Am J Med. 2020 May;133(5):536-543. doi: 10.1016/j.amjmed.2020.01.007. Epub 2020 Feb 1.
2
Association of commuting mode with dyslipidemia and its components after accounting for air pollution in the working population of Beijing, China.在中国北京市的工作人群中,考虑到空气污染因素,通勤模式与血脂异常及其成分之间的关联。
BMC Public Health. 2019 May 22;19(1):622. doi: 10.1186/s12889-019-6887-x.
3
Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome - translating knowledge from systems biology to the bedside.
血清尿酸轨迹与中国代谢功能障碍相关脂肪性肝病风险:一项2019 - 2021年队列健康调查
BMC Public Health. 2025 Feb 17;25(1):653. doi: 10.1186/s12889-024-21214-0.
4
Association between the ratio of serum uric acid to high-density lipoprotein cholesterol and liver fat content: evidence from a Chinese health examination dataset.血清尿酸与高密度脂蛋白胆固醇比值与肝脏脂肪含量之间的关联:来自中国健康体检数据集的证据。
Sci Rep. 2024 Dec 28;14(1):31397. doi: 10.1038/s41598-024-83013-2.
5
The relationship between serum uric acid levels and liver stiffness in patients with type II diabetes mellitus and fatty liver disease.2型糖尿病合并脂肪肝患者血清尿酸水平与肝脏硬度的关系。
Rev Assoc Med Bras (1992). 2024 Dec 16;70(12):e20241013. doi: 10.1590/1806-9282.20241013. eCollection 2024.
6
Serum uric acid and nonalcoholic fatty liver disease.血清尿酸与非酒精性脂肪性肝病
Front Endocrinol (Lausanne). 2024 Nov 28;15:1455132. doi: 10.3389/fendo.2024.1455132. eCollection 2024.
7
Baseline and change in serum lipid and uric acid level over time and incident of nonalcoholic fatty liver disease (NAFLD) in Chinese adults.中国成年人血清脂质和尿酸水平随时间的变化及其与非酒精性脂肪肝(NAFLD)发病的关系。
Sci Rep. 2024 Aug 9;14(1):18547. doi: 10.1038/s41598-024-69411-6.
8
(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease.(+)-硫辛酸可减少非酒精性脂肪性肝病体外模型中线粒体未折叠蛋白反应,减轻氧化应激和衰老。
J Transl Med. 2024 Jan 20;22(1):82. doi: 10.1186/s12967-024-04880-x.
9
A cohort study on the correlation between serum uric acid trajectory and the progression of renal function in patients with Type 2 diabetes mellitus.一项关于 2 型糖尿病患者血清尿酸轨迹与肾功能进展相关性的队列研究。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 May 28;48(5):725-732. doi: 10.11817/j.issn.1672-7347.2023.220539.
10
A simpler definition of MAFLD precisely predicts incident metabolic diseases: a 7-year cohort study.MAFLD 的更简单定义可准确预测代谢性疾病的发生:一项 7 年队列研究。
Hepatol Int. 2023 Oct;17(5):1182-1191. doi: 10.1007/s12072-023-10558-1. Epub 2023 Jun 15.
综述文章:非酒精性脂肪性肝病和代谢综合征之间的共同疾病机制——将系统生物学知识转化到床边。
Aliment Pharmacol Ther. 2019 Mar;49(5):516-527. doi: 10.1111/apt.15163. Epub 2019 Feb 4.
4
Two-Year Changes in Hyperuricemia and Risk of Diabetes: A Five-Year Prospective Cohort Study.高尿酸血症的两年变化与糖尿病风险:一项为期五年的前瞻性队列研究。
J Diabetes Res. 2018 Dec 30;2018:6905720. doi: 10.1155/2018/6905720. eCollection 2018.
5
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science.酒精性和非酒精性脂肪性肝炎:全球视角与新兴科学。
J Gastroenterol. 2019 Mar;54(3):218-225. doi: 10.1007/s00535-018-01542-w. Epub 2019 Jan 14.
6
Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.内脏脂肪指数预测非酒精性脂肪性肝病:一项前瞻性研究,随访 4 年。
Liver Int. 2018 Dec;38(12):2294-2300. doi: 10.1111/liv.13941. Epub 2018 Sep 6.
7
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.特定的肝脏神经酰胺与非酒精性脂肪性肝炎中的胰岛素抵抗、氧化应激和炎症有关。
Diabetes Care. 2018 Jun;41(6):1235-1243. doi: 10.2337/dc17-1318. Epub 2018 Mar 30.
8
Trajectories of Long-Term Normal Fasting Plasma Glucose and Risk of Coronary Heart Disease: A Prospective Cohort Study.长期正常空腹血糖轨迹与冠心病风险:一项前瞻性队列研究。
J Am Heart Assoc. 2018 Feb 13;7(4):e007607. doi: 10.1161/JAHA.117.007607.
9
Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.血清尿酸与非肥胖中国成年人的非酒精性脂肪肝。
Lipids Health Dis. 2017 Oct 16;16(1):202. doi: 10.1186/s12944-017-0531-5.
10
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.